Published in Gene on December 15, 1990
The power to reduce: pyridine nucleotides--small molecules with a multitude of functions. Biochem J (2007) 3.11
Complete biosynthesis of opioids in yeast. Science (2015) 2.78
Dynamic rerouting of the carbohydrate flux is key to counteracting oxidative stress. J Biol (2007) 2.70
Induction of biogenic magnetization and redox control by a component of the target of rapamycin complex 1 signaling pathway. PLoS Biol (2012) 2.15
A stress-responsive system for mitochondrial protein degradation. Mol Cell (2010) 2.05
Engineering redox cofactor regeneration for improved pentose fermentation in Saccharomyces cerevisiae. Appl Environ Microbiol (2003) 1.39
An optimization approach to predicting protein structural class from amino acid composition. Protein Sci (1992) 1.32
The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol Rev Camb Philos Soc (2014) 1.27
Enhanced expression of glucose-6-phosphate dehydrogenase in human cells sustaining oxidative stress. Biochem J (1997) 1.21
Molecular analysis of the gene encoding F420-dependent glucose-6-phosphate dehydrogenase from Mycobacterium smegmatis. J Bacteriol (1998) 1.19
Importance of glucose-6-phosphate dehydrogenase in the adaptive response to hydrogen peroxide in Saccharomyces cerevisiae. Biochem J (1998) 1.14
Cu, Zn superoxide dismutase and NADP(H) homeostasis are required for tolerance of endoplasmic reticulum stress in Saccharomyces cerevisiae. Mol Biol Cell (2009) 0.97
Somatic-cell selection is a major determinant of the blood-cell phenotype in heterozygotes for glucose-6-phosphate dehydrogenase mutations causing severe enzyme deficiency. Am J Hum Genet (1996) 0.94
Los1p, involved in yeast pre-tRNA splicing, positively regulates members of the SOL gene family. Genetics (1996) 0.92
Functions and cellular compartmentation of the thioredoxin and glutathione pathways in yeast. Antioxid Redox Signal (2013) 0.92
Scheffersomyces stipitis: a comparative systems biology study with the Crabtree positive yeast Saccharomyces cerevisiae. Microb Cell Fact (2012) 0.92
Inhibition of triosephosphate isomerase by phosphoenolpyruvate in the feedback-regulation of glycolysis. Open Biol (2014) 0.92
Yap1 accumulates in the nucleus in response to carbon stress in Saccharomyces cerevisiae. Eukaryot Cell (2003) 0.90
Nitric oxide signaling is disrupted in the yeast model for Batten disease. Mol Biol Cell (2007) 0.90
Enhanced expression of genes involved in initial xylose metabolism and the oxidative pentose phosphate pathway in the improved xylose-utilizing Saccharomyces cerevisiae through evolutionary engineering. J Ind Microbiol Biotechnol (2013) 0.88
Isocitrate dehydrogenase is important for nitrosative stress resistance in Cryptococcus neoformans, but oxidative stress resistance is not dependent on glucose-6-phosphate dehydrogenase. Eukaryot Cell (2010) 0.88
Changes in disulfide bond content of proteins in a yeast strain lacking major sources of NADPH. Free Radic Biol Med (2006) 0.84
S-nitroso-proteome in poplar leaves in response to acute ozone stress. PLoS One (2014) 0.84
Lysine-21 of Leuconostoc mesenteroides glucose 6-phosphate dehydrogenase participates in substrate binding through charge-charge interaction. Protein Sci (1992) 0.83
Increasing Anaerobic Acetate Consumption and Ethanol Yields in Saccharomyces cerevisiae with NADPH-Specific Alcohol Dehydrogenase. Appl Environ Microbiol (2015) 0.82
Site-directed mutagenesis to facilitate X-ray structural studies of Leuconostoc mesenteroides glucose 6-phosphate dehydrogenase. Protein Sci (1993) 0.77
The functional molecular mass of the Pasteurella hyaluronan synthase is a monomer. Biochim Biophys Acta (2006) 0.77
Pnc1p supports increases in cellular NAD(H) levels in response to internal or external oxidative stress. Biochemistry (2010) 0.77
Deletion of the glucose-6-phosphate dehydrogenase gene KlZWF1 affects both fermentative and respiratory metabolism in Kluyveromyces lactis. Eukaryot Cell (2006) 0.76
Impaired embryonic development in glucose-6-phosphate dehydrogenase-deficient Caenorhabditis elegans due to abnormal redox homeostasis induced activation of calcium-independent phospholipase and alteration of glycerophospholipid metabolism. Cell Death Dis (2017) 0.75
Inhibitory Role of Greatwall-Like Protein Kinase Rim15p in Alcoholic Fermentation via Upregulating the UDP-Glucose Synthesis Pathway in Saccharomyces cerevisiae. Appl Environ Microbiol (2015) 0.75
Genetic improvement of xylose metabolism by enhancing the expression of pentose phosphate pathway genes in Saccharomyces cerevisiae IR-2 for high-temperature ethanol production. J Ind Microbiol Biotechnol (2017) 0.75
A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature (2000) 47.15
Life with 6000 genes. Science (1996) 41.51
Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science (1999) 36.25
Sequences that regulate the divergent GAL1-GAL10 promoter in Saccharomyces cerevisiae. Mol Cell Biol (1984) 20.61
Making psychological theory useful for implementing evidence based practice: a consensus approach. Qual Saf Health Care (2005) 12.73
A model fungal gene regulatory mechanism: the GAL genes of Saccharomyces cerevisiae. Microbiol Rev (1987) 7.00
Internists' attitudes about clinical practice guidelines. Ann Intern Med (1994) 6.55
Unintended changes in cognition, mood, and behavior arising from cell-based interventions for neurological conditions: ethical challenges. Am J Bioeth (2009) 6.13
COMPASS: a complex of proteins associated with a trithorax-related SET domain protein. Proc Natl Acad Sci U S A (2001) 5.19
Inability of trained nurses to perform basic life support. Br Med J (Clin Res Ed) (1987) 5.08
Green fluorescent protein as a marker for gene expression and subcellular localization in budding yeast. Yeast (1996) 4.53
Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med (1997) 4.47
Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg (1997) 4.47
Surveying Saccharomyces genomes to identify functional elements by comparative DNA sequence analysis. Genome Res (2001) 4.22
Function and regulation of yeast hexose transporters. Microbiol Mol Biol Rev (1999) 3.96
Interventions to prevent weight gain: a systematic review of psychological models and behaviour change methods. Int J Obes Relat Metab Disord (2000) 3.90
Three different regulatory mechanisms enable yeast hexose transporter (HXT) genes to be induced by different levels of glucose. Mol Cell Biol (1995) 3.74
Two glucose transporters in Saccharomyces cerevisiae are glucose sensors that generate a signal for induction of gene expression. Proc Natl Acad Sci U S A (1996) 3.54
Identification of the DNA binding site for NGFI-B by genetic selection in yeast. Science (1991) 3.41
Disability: a model and measurement technique. Br J Prev Soc Med (1976) 3.41
Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer--a meta-analysis. Clin Oncol (R Coll Radiol) (2002) 3.33
Application of operant conditioning procedures to the behavior problems of an autistic child: a follow-up and extension. Behav Res Ther (1967) 3.23
Regulated expression of the GAL4 activator gene in yeast provides a sensitive genetic switch for glucose repression. Proc Natl Acad Sci U S A (1991) 3.00
Grr1 of Saccharomyces cerevisiae is connected to the ubiquitin proteolysis machinery through Skp1: coupling glucose sensing to gene expression and the cell cycle. EMBO J (1997) 2.97
Regulated nuclear translocation of the Mig1 glucose repressor. Mol Biol Cell (1997) 2.96
Glucose sensing and signaling by two glucose receptors in the yeast Saccharomyces cerevisiae. EMBO J (1998) 2.96
Genetic evidence that zinc is an essential co-factor in the DNA binding domain of GAL4 protein. Nature (1987) 2.71
Development of the human coagulation system in the full-term infant. Blood (1987) 2.69
Two systems of glucose repression of the GAL1 promoter in Saccharomyces cerevisiae. Mol Cell Biol (1990) 2.65
Community-based cancer screening for underserved women: design and baseline findings from the Breast and Cervical Cancer Intervention Study. Prev Med (2001) 2.35
GRR1 of Saccharomyces cerevisiae is required for glucose repression and encodes a protein with leucine-rich repeats. Mol Cell Biol (1991) 2.34
Changing clinicians' behavior: a randomized controlled trial of fees and education. J Dent Res (2008) 2.34
Establishing a therapeutic range for heparin therapy. Ann Intern Med (1993) 2.31
The work of a clinical psychologist in primary care. J R Coll Gen Pract (1978) 2.31
Characterization of three related glucose repressors and genes they regulate in Saccharomyces cerevisiae. Genetics (1998) 2.27
Baseline staging tests in primary breast cancer: a practice guideline. CMAJ (2001) 2.22
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination. J Thromb Haemost (2004) 2.21
tRNA genes as transcriptional repressor elements. Mol Cell Biol (1994) 2.10
Predictors of emotional outcomes of intensive care. Anaesthesia (2005) 2.10
The impact of prenatal screening and diagnostic testing upon the cognitions, emotions and behaviour of pregnant women. J Psychosom Res (1989) 2.06
Galactose as a gratuitous inducer of GAL gene expression in yeasts growing on glucose. Gene (1989) 2.04
Multicentre survey of radiologically inserted gastrostomy feeding tube (RIG) in the UK. Clin Radiol (2012) 2.04
Two zinc-finger-containing repressors are responsible for glucose repression of SUC2 expression. Mol Cell Biol (1996) 1.92
Maturation of the hemostatic system during childhood. Blood (1992) 1.89
The nuclear exportin Msn5 is required for nuclear export of the Mig1 glucose repressor of Saccharomyces cerevisiae. Curr Biol (1999) 1.89
Mutations that inactivate a yeast transcriptional regulatory protein cluster in an evolutionarily conserved DNA binding domain. Proc Natl Acad Sci U S A (1987) 1.86
Rgt1p of Saccharomyces cerevisiae, a key regulator of glucose-induced genes, is both an activator and a repressor of transcription. Mol Cell Biol (1996) 1.85
Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol (1990) 1.78
Educational package on hypertension for primary care physicians. Can Med Assoc J (1984) 1.73
Systematic overview of the evidence for brachytherapy in clinically localized prostate cancer. CMAJ (2001) 1.71
Does motor imagery training improve hand function in chronic stroke patients? A pilot study. Clin Rehabil (2004) 1.69
Analysis of URSG-mediated glucose repression of the GAL1 promoter of Saccharomyces cerevisiae. Genetics (1992) 1.64
Molecular cloning of the GAL80 gene from Saccharomyces cerevisiae and characterization of a gal80 deletion. Gene (1984) 1.64
Development of a self-administered questionnaire to measure women's knowledge of prenatal screening and diagnostic tests. J Psychosom Res (1988) 1.60
Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study. Thromb Haemost (2001) 1.58
Development of the human coagulation system in the healthy premature infant. Blood (1988) 1.57
Cell-based interventions for neurologic conditions: ethical challenges for early human trials. Neurology (2008) 1.57
Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus: a cross-sectional study. Blood (1992) 1.55
The psychological effects of false-positive results in prenatal screening for fetal abnormality: a prospective study. Prenat Diagn (1992) 1.53
Increased thrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state. Blood (1993) 1.52
Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes. Eur Heart J (2002) 1.51
Expression of the SUC2 gene of Saccharomyces cerevisiae is induced by low levels of glucose. Yeast (1997) 1.49
Frequency and mechanism of neonatal thrombocytopenia. J Pediatr (1986) 1.49
Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients. Intensive Care Med (2004) 1.48
Screening for Down's syndrome. BMJ (1988) 1.48
A tuberculin skin test survey among Afghan children in Kabul. Int J Tuberc Lung Dis (2004) 1.47
Suicide inactivation of bacterial cystathionine gamma-synthase and methionine gamma-lyase during processing of L-propargylglycine. Biochemistry (1979) 1.47
Sources of support and the physical and mental well-being of young women with breast cancer. Soc Sci Med (2001) 1.44
An unusual case of prolonged tinnitus following low-dose amitriptyline. J Psychopharmacol (2008) 1.44
Suppressors reveal two classes of glucose repression genes in the yeast Saccharomyces cerevisiae. Genetics (1994) 1.42
Two different repressors collaborate to restrict expression of the yeast glucose transporter genes HXT2 and HXT4 to low levels of glucose. Mol Cell Biol (1996) 1.40
Hirudin causes more bleeding than heparin in a rabbit ear bleeding model. J Lab Clin Med (1998) 1.40
Genetic and molecular characterization of GAL83: its interaction and similarities with other genes involved in glucose repression in Saccharomyces cerevisiae. Genetics (1993) 1.38
Systematic analysis of S. cerevisiae chromosome VIII genes. Yeast (1999) 1.31
Drainage of CSF through lymphatic pathways and arachnoid villi in sheep: measurement of 125I-albumin clearance. Neuropathol Appl Neurobiol (1996) 1.30
Increasing galactose consumption by Saccharomyces cerevisiae through metabolic engineering of the GAL gene regulatory network. Nat Biotechnol (2000) 1.27
Phosphorylated forms of GAL4 are correlated with ability to activate transcription. Mol Cell Biol (1990) 1.26
Knowledge may not be the best target for strategies to influence evidence-based practice: using psychological models to understand RCT effects. Int J Behav Med (2009) 1.20
Factors influencing the uptake of screening for open neural-tube defects and amniocentesis to test for Down's syndrome. Br J Obstet Gynaecol (1989) 1.19
Cognitive impairment, emotional disorder and length of stay of elderly patients in a district general hospital. Br J Med Psychol (1987) 1.19
Direct cloning of yeast genes from an ordered set of lambda clones in Saccharomyces cerevisiae by recombination in vivo. Genetics (1993) 1.18
Factors predicting the guideline compliant supply (or non-supply) of non-prescription medicines in the community pharmacy setting. Qual Saf Health Care (2006) 1.17
Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor. J Thromb Haemost (2004) 1.14
Promoter elements determining weak expression of the GAL4 regulatory gene of Saccharomyces cerevisiae. Mol Cell Biol (1993) 1.14
Anxiety in surgical patients. Psychol Med (1980) 1.14
Intrusiveness of illness and quality of life in young women with breast cancer. Psychooncology (1998) 1.12
Behavioural treatment of an eating problem. Nurs Times (1976) 1.11
Practice and career satisfaction among physiatrists. A national survey. Am J Phys Med Rehabil (1997) 1.11
Vitamin K deficiency and D-dimer levels in the intensive care unit: a prospective cohort study. Blood Coagul Fibrinolysis (2002) 1.11
Contribution of extracranial lymphatics and arachnoid villi to the clearance of a CSF tracer in the rat. Am J Physiol (1999) 1.10
Mechanistic studies on the pyridoxal phosphate enzyme 1-aminocyclopropane-1-carboxylate deaminase from Pseudomonas sp. Biochemistry (1981) 1.08
Binding of the glucose-dependent Mig1p repressor to the GAL1 and GAL4 promoters in vivo: regulationby glucose and chromatin structure. Nucleic Acids Res (1999) 1.07
Preliminary observations on the pharmacokinetics of human lymphoblastoid interferon given by intramuscular injection. Clin Oncol (1982) 1.07
Modifiable and fixed factors predicting quality of life in people with colorectal cancer. Br J Cancer (2011) 1.07
Failure of weight reduction to reduce mildly elevated blood pressure: a randomized trial. J Hypertens (1984) 1.07
[Resection of lung metastases: long-term results and prognostic analysis based on 5206 cases--the International Registry of Lung Metastases]. Zentralbl Chir (1999) 1.06
In vivo mutational analysis of the NGFI-A zinc fingers. J Biol Chem (1992) 1.06
An antithrombin III assay based on factor Xa inhibition provides a more reliable test to identify congenital antithrombin III deficiency than an assay based on thrombin inhibition. Thromb Haemost (1993) 1.05